FibroGen/$FGEN
About FibroGen
Ticker
Industry
Employees
FibroGen Metrics
$59M
-
-$1.22
0.73
-
Price and volume
Market cap
$59M
Beta
0.73
52-week high
$2.93
52-week low
$0.18
Average daily volume
1.4M
Financial strength
Current ratio
1.283
Quick ratio
0.975
Long term debt to equity
-45.456
Total debt to equity
-46.097
Interest coverage (TTM)
-6.00%
Management effectiveness
Return on assets (TTM)
-20.53%
Return on equity (TTM)
76.86%
Valuation
Price to revenue (TTM)
0.325
Price to book
-0.24
Price to tangible book (TTM)
-0.24
Price to free cash flow (TTM)
-0.464
Growth
Revenue change (TTM)
16.15%
Earnings per share change (TTM)
-59.96%
3-year revenue growth (CAGR)
-14.08%
3-year earnings per share growth (CAGR)
-19.34%
What the Analysts think about FibroGen
Analyst Ratings
FibroGen Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
FibroGen Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
FibroGen News
FAQs
What’s the current market cap for FibroGen stock?
What is the P/E ratio for FibroGen stock?
Does FibroGen stock pay dividends?
No, FibroGen (FGEN) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next FibroGen dividend payment date?
FibroGen (FGEN) stock does not pay dividends to its shareholders.
What is the beta indicator for FibroGen?
FibroGen (FGEN) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.